Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moran Zarfati

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Harefuah|April 15, 2024
[PATIENT BLOOD MANAGEMENT - IT IS IMPOSSIBLE TO IGNORE THIS POLICY]Andrei Braester, Luiza Akria, Moran Zarfati, et al.
Angiogenesis|November 3, 2018
Extracellular vesicles of multiple myeloma cells utilize the proteasome inhibitor mechanism to moderate endothelial angiogenesisMoran Zarfati, Irit Avivi, Benjamin Brenner, et al.
Annals of Hematology|May 22, 2024
Flow-cytometry Assessment of DNA content and Immunophenotyping of Immune-cells in Lymph-node-specimens as a Potential Diagnostic Signature of Aggressiveness in B-Non-Hodgkin LymphomasDavid Azoulay, Tal Tapuchi, Ohad Ronen, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Harefuah|April 15, 2024
[PATIENT BLOOD MANAGEMENT - IT IS IMPOSSIBLE TO IGNORE THIS POLICY]Andrei Braester, Luiza Akria, Moran Zarfati, et al.
Angiogenesis|November 3, 2018
Extracellular vesicles of multiple myeloma cells utilize the proteasome inhibitor mechanism to moderate endothelial angiogenesisMoran Zarfati, Irit Avivi, Benjamin Brenner, et al.
Annals of Hematology|May 22, 2024
Flow-cytometry Assessment of DNA content and Immunophenotyping of Immune-cells in Lymph-node-specimens as a Potential Diagnostic Signature of Aggressiveness in B-Non-Hodgkin LymphomasDavid Azoulay, Tal Tapuchi, Ohad Ronen, et al.
Pageof 1